Licensing Publicly Funded Knowledge

Health Action Internationalis a non-profit organisation that conducts research and advocacy to advance policies that enable access to medicines and rational medicine use for all people around the world. We pursue advocacy from the patient level up to the highest levels of government through our ‘official relations’ status with the World Health Organization and respected relationship with the European Medicines Agency. To safeguard our objectivity and integrity, we are resolutely independent of the pharmaceutical industry and protect ourselves from all other conflicts of interest.

Health Action International

How can we ensure that medicines originating in Dutch public institutions are affordable and accessible to all?

Utrecht University, Library, Boothzaal

Unfortunately, registration is now closed. For last minute requests, please contact us directly at comms@haiweb.org or +31 (0) 20 412 4523.

The high price of new medicines is often attributed to the cost of early stage research and development (R&amp;D), which allegedly requires huge financial investment. However, the basic research on which drug development is built often originates in public institutions or is funded by government grants.The Netherlands has been a pioneer in addressing the shortcomings of the current R&amp;D model and exploring possible alternative innovation mechanisms. Yet, research originating in Dutch public research institutions has been used to develop medicines with huge price tags. Health Action International, Wemos and Utrecht University will hold an event to bring together advocates, researchers and academics to discuss latest reports and tools on the issue, and how to ensure the guidelines they contain are made operational and embraced by all stakeholders for the benefit of patients. Following the panel discussion there will be a Q&amp;A session with the audience. SPEAKERS AND PANELISTS<ul><li>Prof. Dr. Frank Miedema | Chair NFU Social Responsible Licensing Principles Working Group, UMCU</li><li>Ella Weggen | Senior Global Health Advocate at Wemos</li><li>Jaume Vidal | Senior Policy Advisor at Health Action International</li><li>Dr. Andre Broekmans | Board Member Utrecht Centre for Affordable Biotherapeutics</li><li>Dr. Jennifer Sellin | Assistant Professor at Department of International and European Law, Maastricht University (TBC)</li><li>Victoria Defelippe | President at Universities Allied for Essential Medicines the Netherlands (UAEM NL)</li></ul>Moderators: Prof. Dr. Aukje Mantel-Teeuwisse and Prof. Dr. Bert Leufkens | Utrecht University

Our {communityGuidelinesLink} describe the sort of content we prohibit on Eventbrite. If you suspect an event may be in violation, you can report it to us so we can investigate.

To report other categories of prohibited or illegal content, submit {link}

Registrations are closed

Licensing Publicly Funded Knowledge

More events from Health Action International

Discover more events from Health Action International, from Government to other experiences you might love.

Still looking for the right event?

Explore all events in Utrecht and filter by date, category, and more to find the perfect fit.

Registrations are closed

Licensing Publicly Funded Knowledge

More events from Health Action International

Discover more events from Health Action International, from Government to other experiences you might love.

You might also like...

Browse more events with different dates, prices, and formats to find your next great experience.

Still looking for the right event?

Explore all events in Utrecht and filter by date, category, and more to find the perfect fit.